Seer (SEER) Change in Receivables (2020 - 2026)
Seer (SEER) posted quarterly Change in Receivables of -$1.7 million for Q1 2026, down 93.83% year-over-year from -$27.5 million in Q1 2025, and down 313.33% quarter-over-quarter from $795000.0 in Q4 2025.
Seer (SEER) Change in Receivables (2020 - 2026) Analysis & Trends
Seer's Change in Receivables history runs 7 years deep, the most recent figure standing at -$1.7 million for Q1 2026.
- In Q1 2026, Change in Receivables fell 93.83% year-over-year to -$1.7 million; the TTM figure through Mar 2026 stood at -$1.1 million (down 37.94% YoY), while the FY2025 annual figure was -$277000.0, up 43.12% from the prior year.
- Change in Receivables for Q1 2026 stood at -$1.7 million, down from $795000.0 in the prior quarter.
- The five-year high for Change in Receivables was $1.4 million in Q3 2023, with the low at -$1.7 million in Q1 2026.
- The 5-year median for Change in Receivables is $165000.0 (2023), against an average of $6588.2.
- The sharpest annual moves came in 2024 and 2025: Change in Receivables plunged 443.03% in 2024, then surged 459.73% in 2025.
- Seer's Change in Receivables stood at $640000.0 in 2022, then sank by 260.94% to -$1.0 million in 2023, then jumped by 78.54% to -$221000.0 in 2024, then soared by 459.73% to $795000.0 in 2025, then slumped by 313.33% to -$1.7 million in 2026.
- Business Quant data shows SEER's Change in Receivables at -$1.7 million in Q1 2026, $795000.0 in Q4 2025, and -$557000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 117.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -483,662.49 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 31.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 37.16 Mn |
| 10 | Seer | 230.63 Mn | 230.63 Mn | 1.51 Mn | -824,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -824,000.00 |
| Jun 30, 2026 | -824,000.00 |
| Mar 31, 2026 | -1.70 Mn |
| Mar 31, 2026 | -1.70 Mn |
| Dec 31, 2025 | 795,000.00 |
| Dec 31, 2025 | 795,000.00 |
| Sep 30, 2025 | -557,000.00 |
| Sep 30, 2025 | -557,000.00 |
| Jun 30, 2025 | 360,000.00 |
| Jun 30, 2025 | 360,000.00 |
| Mar 31, 2025 | -875,000.00 |
| Mar 31, 2025 | -875,000.00 |
| Dec 31, 2024 | -221,000.00 |
| Dec 31, 2024 | -221,000.00 |
| Sep 30, 2024 | 749,000.00 |
| Sep 30, 2024 | 749,000.00 |
| Jun 30, 2024 | -449,000.00 |
| Jun 30, 2024 | -449,000.00 |
| Mar 31, 2024 | -566,000.00 |
| Mar 31, 2024 | -566,000.00 |